NCT04059848

Brief Summary

The purpose of this study was to investigate the effects of the combination treatment strategy. A randomized, double-blinded and sham-stimulation study was conducted. Twenty-six participants with chronic stroke (onset \> 6 months) were assigned into one of three groups (tDCS combined with NMES, tDCS combined with sham NMES, or sham tDCS combined with sham NMES) by block randomization. In addition to conventional rehabilitation, all subjects received an additional protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily). The UE subscale of Fugl-Meyer assessment (UE-FMA) and Action Research Arm Test (ARAT) as primary outcome measures were assessed at beginning of the intervention, after 3-week of treatment, and one-month follow-up. No significant differences in the primary outcome measures at post-treatment and one-month follow-up were found among the tDCS combined with NMES group (n=9), tDCS combined with sham NMES group (n=9), and the sham tDCS combined with sham NMES group (n=8). However, significant changes in UE-FMA (from baseline to post-treatment, p= .02) and ARAT (from baseline to post-treatment, p= .04) score were found for the tDCS combined with NMES group. This preliminary study reveals that the tDCS combined with NMES appears to be beneficial to UE motor recovery after stroke but is not superior to the tDCS alone.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 13, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2019

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2019

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 14, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 16, 2019

Completed
Last Updated

August 16, 2019

Status Verified

August 1, 2019

Enrollment Period

2.5 years

First QC Date

August 14, 2019

Last Update Submit

August 15, 2019

Conditions

Keywords

Transcranial direct current stimulationNeuromuscular electrical stimulationStrokeRehabilitation

Outcome Measures

Primary Outcomes (2)

  • upper extremity subscale of Fugl-Meyer assessment

    The Fugl-Meyer assessment consists of the 33-item upper-extremity (UE-FM) and 17-item lower-extremity subscales.(Fugl-Meyer et al., 1975) The items of the FM are mainly scored on a 3-point scale, from 0 to 2. The total score of the UE-FM ranges from 0 to 66.

    at beginning of the intervention, after 3-week of treatment, and one-month follow-up

  • Action Research Arm Test

    The ARAT(Lyle, 1981) has 19 items in four categories: grasp, grip, pinch, and gross movement. Each item is graded on a 4-point scale, from 0 to 3. The total score has a range of 0 to 57.

    at beginning of the intervention, after 3-week of treatment, and one-month follow-up

Study Arms (3)

tDCS combined with NMES

EXPERIMENTAL

In addition to conventional rehabilitation, all subjects received an additional tDCS combined with NMES protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily).

Combination Product: tDCS(Intelect Mobile Stimulation and Combination, DJO, France)Combination Product: NMES(Enraf Nonius, Endomed-182, Netherlands)

tDCS combined with sham NMES

ACTIVE COMPARATOR

In addition to conventional rehabilitation, all subjects received an additional tDCS combined with sham NMES protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily).

Combination Product: tDCS(Intelect Mobile Stimulation and Combination, DJO, France)Combination Product: NMES(Enraf Nonius, Endomed-182, Netherlands)

sham tDCS combined with sham NMES

SHAM COMPARATOR

In addition to conventional rehabilitation, all subjects received an additional sham tDCS combined with sham NMES protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily).

Combination Product: tDCS(Intelect Mobile Stimulation and Combination, DJO, France)Combination Product: NMES(Enraf Nonius, Endomed-182, Netherlands)

Interventions

sham tDCS combined with sham NMEStDCS combined with NMEStDCS combined with sham NMES
sham tDCS combined with sham NMEStDCS combined with NMEStDCS combined with sham NMES

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First onset
  • Ischemic stroke
  • Stroke onset \> 6 months
  • Brunnstrom recovery stage: ≧3
  • Modified Ashworth Scale Elbow flexor : ≦3

You may not qualify if:

  • Severe language or cognitive impairment
  • Orthopaedic or neurological problems
  • Pregnancy
  • Contraindications for tDCS or NMES

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2019

First Posted

August 16, 2019

Study Start

January 13, 2017

Primary Completion

July 30, 2019

Study Completion

July 31, 2019

Last Updated

August 16, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share